fax: (33) 1 53 72 51 58
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Hepatobiliary Malignancies
You have full text access to this OnlineOpen article
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations†
Article first published online: 1 FEB 2008
DOI: 10.1002/hep.22256
Copyright © 2008 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S. and Zucman-Rossi, J. (2008), MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47: 1955–1963. doi: 10.1002/hep.22256
- †
Potential conflict of interest: Nothing to report.
- ‡
fax: (33) 1 53 72 51 58
Publication History
- Issue published online: 28 MAY 2008
- Article first published online: 1 FEB 2008
- Accepted manuscript online: 1 FEB 2008 12:00AM EST
- Manuscript Accepted: 24 JAN 2008
- Manuscript Received: 4 DEC 2007
Funded by
- ANRS (Agence Nationale de Recherches sur le Sida et les hépatites)
- INSERM (Réseaux de Recherche Clinique et Réseaux de Recherche en Santé des Populations)
- “Carte d'Identité des Tumeurs,” which was initiated, developed, and funded by the Ligue Nationale Contre le Cancer
- ANRS doctoral fellowship
- INSERM and Centre Hospitalier Universitaire de Bordeaux
References
- 1. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27–S34.
- 2, . Genetics of hepatocellular tumors. Oncogene 2006; 25: 3778–3786.
- 3, , , , . Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007; 27: 55–76.
- 4, , , . Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926–929.
- 5, , , , , , et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. HEPATOLOGY 2007; 46: 740–748.
- 6, , , , , , et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. HEPATOLOGY 2006; 43: 515–524.
- 7, , , , , , et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. HEPATOLOGY 2007; 45: 42–52.
- 8, , , , , , et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001; 120: 1763–1773.
- 9. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.
- 10. The functions of animal microRNAs. Nature 2004; 431: 350–355.
- 11. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563–568.
- 12, , , , , , et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99: 671–678.
- 13, , , , , . MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647–658.
- 14, , , , , . Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537–2545.
- 15, , , , , , et al. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet 2005; 14: 603–614.
- 16, . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857–866.
- 17, , . Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163–170.
- 18, , , , . Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005; 309: 1577–1581.
- 19, , , , , , et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67: 6092–6099.
- 20, , , , , , et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007; 210: 370–377.
- 21, , , , . A limited set of human microRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006; 91: 3584–3591.
- 22, , . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682–688.
- 23, , , , , , et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282: 23716–23724.
- 24, , , , , , et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007; 14: 791–798.
- 25, , , , , , et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2007. doi://10.1038/sj.onc.1210856. Available at: http://www.nature.com.
- 26, , , , , , et al. MYCN regulates oncogenic microRNAs in neuroblastoma. Int J Cancer 2007; 122: 699–704.
- 27, , , . MicroRNAs join the p53 network—another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7: 819–822.
- 28, , . Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91: 209–217.
- 29, , , , , , et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007; 282: 14437–14446.
- 30